UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Compound Global Advisors LLC

Compound Global Advisors LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 72.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 612 shares of the healthcare conglomerate’s stock after selling 1,650 shares during the quarter. UnitedHealth Group accounts for approximately 1.9% of Compound Global Advisors LLC’s holdings, making the stock its 21st largest position. Compound Global Advisors LLC’s holdings in UnitedHealth Group were worth $321,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Citizens National Bank Trust Department raised its stake in UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH lifted its holdings in shares of UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new position in UnitedHealth Group during the 4th quarter worth $515,000. Full Sail Capital LLC boosted its holdings in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares during the period. Finally, Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth about $39,413,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 4.4%

Shares of UNH opened at $325.83 on Wednesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a market capitalization of $295.57 billion, a P/E ratio of 13.64, a P/E/G ratio of 1.48 and a beta of 0.45. The business’s 50-day moving average price is $331.91 and its 200 day moving average price is $451.20.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter last year, the company posted $6.91 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.71%. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Analysts Set New Price Targets

Several brokerages have commented on UNH. UBS Group dropped their price target on shares of UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating on the stock in a research note on Wednesday, June 25th. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. Finally, HSBC restated a “reduce” rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $415.57.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Kristen Gil bought 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The stock was bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director directly owned 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction dated Friday, May 16th. The shares were bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock valued at $31,607,768 in the last 90 days. Corporate insiders own 0.28% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.